Click Here For COVID-19 (Coronavirus) Studies

RecruitMe Clinical Trial

HOPE in Action Prospective Multi-center, Clinical Trial of HIV+ Deceased Donor Liver Transplants for HIV+ Recipients
A Study of HIV+ Deceased Donor Liver Transplants for HIV+ Recipients (Liver Transplant)
Sponsor:NIAID
Enrolling:Male and Female Patients
Minimum Age:18 years old
IRB Number:AAAS2561
U.S. Government ID:NCT03734393
Contact: Marcus Pereira, MD, MPH: 212-305-3839 / mp2323@cumc.columbia.edu
Additional Study Information:

The primary objective of this study is to determine if an HIV-infected donor liver (HIVD+) transplant issafe with regards to major transplant-related and HIV-related complications. This study will evaluate if receiving a liver transplant from an HIV-infected deceased liver donor is safe with regards to survival and major transplant-related and HIV-related complications compared to receiving a liver from an HIV-uninfected deceased liver donor (HIVD-). Those participants who have accepted an HIVD- organ will be randomized to be followed in the full study or followed in the nestedobservational group.

Do You Qualify?
Are you 18 years of age or older?YesNo
Are you HIV-positive?YesNo
Are you eligible for a liver transplant?YesNo
Submit
Cancel
Investigator
Marcus Pereira, MD, MPH
You may be eligible for this study

Place Holder




Who Can I Contact?
For more information, please contact:
Marcus Pereira, MD, MPH
Email: mp2323@cumc.columbia.edu
Phone: 212-305-3839